Methods and sensors for detecting bacterial nucleic acids

By immobilizing specific nucleic acid probes on an EGFET sensor and detecting changes in electrical signals before and after a sample, the problems of long detection time and difficulty in distinguishing Gram bacteria in sepsis detection are solved, achieving rapid and accurate bacterial nucleic acid detection.

CN121002369APending Publication Date: 2025-11-21NOVASCOPE BIOCHIPS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202480025710.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-05-09
Filing Date
2024-05-08
Publication Date
2025-11-21

AI Technical Summary

Technical Problem

Current technologies require a significant amount of time to detect sepsis. Traditional methods, such as whole blood culture, take several days to detect bacteria and have difficulty quickly distinguishing between Gram-positive and Gram-negative bacteria, affecting treatment time and effectiveness.

Method used

By employing an extended gate field-effect transistor (EGFET) sensor, specific nucleic acid probes are fixed in its sensing area to detect changes in electrical signals before and after a sample is taken, enabling rapid differentiation of nucleic acids from Gram-positive and Gram-negative bacteria.

Benefits of technology

It shortens the detection time from several days to just a few hours, enabling the differentiation of Gram bacteria, thus improving detection efficiency and accuracy, and making it suitable for rapid clinical diagnosis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

A method for detecting bacterial nucleic acids is provided. The method includes the steps of: providing an extended gate field effect transistor (EGFET) having a sensing region; fixing a nucleic acid probe on the sensing area, wherein the nucleic acid probe has specificity for gram-negative bacteria or gram-positive bacteria; providing a control group sample on a sensing region of the EGFET; detecting a first electrical signal of the EGFET after the control group sample is provided onto a sensing region of the EGFET; providing a sample on a sensing region of the EGFET; detecting a second electrical signal of the EGFET after the sample is provided onto a sensing region of the EGFET; and comparing the first electric signal with the second electric signal to judge whether bacterial nucleic acid exists in the sample.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The entire contents of the electronic sequence listing (sequencelisting.xml, size: 7.96 KB, creation date: April 16, 2024) is incorporated herein by reference. TECHNICAL FIELD

[0002] The present application relates to a method and a sensor for detecting bacterial nucleic acids, and in particular to a method and a sensor for detecting bacterial nucleic acids using an EGFET. BACKGROUND

[0003] Sepsis is an extreme response of the body to infection, mainly due to the increase in invasive procedures, open wounds, chemotherapy, and transplants (Esper et al., Critical care, 2009. 13(1): p. 1-3; Minasyan et al, Scandinavian journal of trauma, resuscitation and emergency medicine, 2019. 27(1): p. 1-22). Most sepsis is caused by bacterial infections in hospitals and communities, and the bacteria causing sepsis can be classified into Gram-positive bacteria (Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Listeria, etc.) and Gram-negative bacteria (Escherichia coli, Salmonella, Klebsiella pneumoniae, etc.). Among these bacteria, Escherichia coli and Staphylococcus aureus are the most common species of bacterial infection causing sepsis (Franco-Paredes, Core concepts in clinical infectious diseases (CCCID). 2016: Academic Press; Burdino et al., Diagnostic Microbiology and Infectious Disease, 2014. 79(3): p. 287-292; Lisowska-Łysiak et al., Pol J Microbiol, 2021. 70(1): p. 13-23).

[0004] Antibiotic therapy is the most common type of drug treatment used to combat bacterial infections in hospitals. However, the drug treatment, delivery time, and the type of antibiotic used for sepsis are closely related to the detection and prognosis of sepsis. Improper use of antibiotics can lead to increased adverse reactions, secondary infections, and drug interactions (Llor et al., Therapeutic Advances in Drug Safety, 2014. 5(6): p. 229-241).

[0005] In clinical testing, blood culture (the gold standard) represents a reference method for detecting bacteria or fungi. The method for detecting sepsis still follows the gold standard method of whole blood diagnosis and uses other biochemical tests to improve the sensitivity and specificity of detection. While the traditional detection method (whole blood culture diagnosis) has sufficient sensitivity for detecting a single bacterium, it takes additional time for the bacteria to grow to amplify the signal, which is relatively time-consuming. The detection of sepsis takes a lot of time, and the patient's symptoms can worsen within a few days to hours.

[0006] Using 16S rRNA sequences as a method for studying microbial detection and identification, since this 16S rRNA sequence is a conserved region in bacterial genes almost in all bacteria, it can be an effective method for identifying bacteria (Janda et al., Journal of Clinical Microbiology, 2007. 45(9): p. 2761-2764; Srinivasan et al., PLoS One, 2015. 10(2): p. e0117617; Klausegger et al., Journal of Clinical Microbiology, 1999. 37(2): p. 464-466; Shi-qiang et al., Journal of Zhejiang University-SCIENCE A, 2000. 1(2): p. 222-226). Several research teams have previously published clinical molecular detection of diseases and suitable targets using the 16S rRNA sequence of the conserved region specific to bacteria, including clinical studies such as cystic fibrosis, endophthalmitis, and sepsis (Aarthi et al., Microbiological Research, 2013. 168(8): p. 497-503; Carroll et al., Journal of Clinical Microbiology, 2000. 38(5): p. 1753-1757; Shang et al., Pediatric Research, 2005. 58(1): p. 143-148; Abayasekara et al., BMC Infectious Diseases, 2017. 17(1): p. 631).

[0007] A design of DNA sequences capable of differentiating between Gram-positive and Gram-negative bacteria has been published as probes to identify bacterial species in samples in real-time PCR (Burdino et al., Diagnostic Microbiology and Infectious Disease, 2014. 79(3): p. 287-292; Shang et al., Pediatric Research, 2005. 58(1): p. 143-148). Identification of Gram-positive and Gram-negative bacteria can be achieved by detecting nucleic acids in bacterial samples, and this method is expected to replace the traditional Gram staining method for identifying bacteria. The method of detecting bacterial nucleic acids reduces the time required for detection from 3-14 days to 3 days.

[0008] Field-effect transistors (FETs) are one of the most powerful biosensors, with excellent sensitivity and specificity, and have the advantage of low-cost, real-time, and label-free bio-sensing applications. By modifying the surface of FETs with probes to detect targets such as nucleic acids and proteins, the sensor can directly convert the target signal on the FET surface into an electronic signal (Syu et al., ECS Journal of Solid State Science and Technology, 2018. 7(7): p. Q3196-Q3207; Salami et al., Biosensors and Bioelectronics, 2019. 10: p. 1-11; Sadighbayan et al., TrAC Trends in Analytical Chemistry, 2020. 133: p. 116067; Hu et al., Scientific Reports, 2018. 8(1): p. 12598).

[0009] The main application of extended gate field-effect transistors (EGFET) is to detect ionic species, pH, and especially biomolecules such as antigens, cells, nucleic acids, and proteins by sensing the functionalization of the surface (Pan et al., Sensors and Actuators B: Chemical, 2010. 144(1): p. 139-145; Pan et al., Journal of Alloys and Compounds, 2022. 903: p. 163955; Bartold et al., Biosensors and Bioelectronics, 2022. 208: p. 114203; Wenga et al., Biosensors and Bioelectronics, 2013. 40(1): p. 141-146; Sakata et al., Japanese Journal of Applied Physics, 2005. 44(4B): p. 2860-2863; Yin et al., Materials Chemistry and Physics, 2001. 70(1): p. 12-16).

[0010] To shorten the clinical detection time and quickly distinguish the gram type of bacteria, the present disclosure provides a method and a sensor for detecting bacterial nucleic acid. SUMMARY

[0011] One object of the present disclosure is to provide a method for detecting bacterial nucleic acid. The method for detecting bacterial nucleic acid comprises the steps of: providing an extended gate field-effect transistor (EGFET) having a sensing region; immobilizing a nucleic acid probe on the sensing region, wherein the nucleic acid probe has specificity for gram-negative bacteria or gram-positive bacteria; providing a control group sample on the sensing region of the EGFET; detecting a first electrical signal of the EGFET after the control group sample is provided on the sensing region of the EGFET; providing a sample on the sensing region of the EGFET; detecting a second electrical signal of the EGFET after the sample is provided on the sensing region of the EGFET; and comparing the first electrical signal and the second electrical signal to determine whether bacterial nucleic acid is present in the sample.

[0012] In one embodiment, the nucleic acid probe comprises the sequence of SEQ ID NO:1, which is specific to the Gram-negative bacteria.

[0013] In one embodiment, the Gram-negative bacterium is *Escherichia coli* (E. coli). E. coli ).

[0014] In one embodiment, the nucleic acid probe comprises the sequence of SEQ ID NO:2, which is specific to the Gram-positive bacteria.

[0015] In one embodiment, the Gram-positive bacterium is Staphylococcus aureus (Staphylococcus aureus). S. aureus ).

[0016] In one embodiment, the sample is diluted with Tris-HCl buffer.

[0017] In one embodiment, the concentration of the Tris-HCl buffer is 25 mM.

[0018] In one embodiment, the first electrical signal is converted into a first I D -V G The curve, and the second electrical signal is converted into a second I D -V G curve.

[0019] In one embodiment, when the first I D -V G Curve and the second I D -V G When the curve is shifted, bacterial nucleic acid is present in the sample.

[0020] In one embodiment, the nucleic acid probe comprises a sequence of SEQ ID NO:1 that is specific to the Gram-negative bacteria, and the concentration of bacterial nucleic acid of the Gram-negative bacteria in the sample is at least 10 ag / μL.

[0021] In one embodiment, the nucleic acid probe comprises the sequence of SEQ ID NO: 2, and the concentration of the Gram-positive bacteria in the sample is at least 1 fg / μL.

[0022] Another object of the present disclosure is to provide a method of detecting bacterial nucleic acid. The method comprises the steps of: providing an extended gate field-effect transistor (EGFET) having a sensing region; immobilizing a nucleic acid probe on the sensing region, wherein the nucleic acid probe has specificity for gram-negative bacteria or gram-positive bacteria; providing a control group sample on the sensing region of the EGFET; detecting a first electrical signal of the EGFET after the control group sample is provided on the sensing region of the EGFET; providing a sample on the sensing region of the EGFET; detecting a second electrical signal of the EGFET after the sample is provided on the sensing region of the EGFET; and determining an amount of bacterial nucleic acid in the sample based on the first electrical signal and the second electrical signal.

[0023] In one embodiment, the nucleic acid probe comprises a sequence of SEQ ID NO: 1 having specificity for the gram-negative bacteria.

[0024] In one embodiment, the gram-negative bacteria is Escherichia coli (E. coli). E. coli ).

[0025] In one embodiment, the nucleic acid probe comprises a sequence of SEQ ID NO: 2 having specificity for the gram-positive bacteria.

[0026] In one embodiment, the gram-positive bacteria is Staphylococcus aureus (S. aureus). S. aureus ).

[0027] In one embodiment, the sample is diluted with Tris-HCl buffer.

[0028] In one embodiment, the concentration of the Tris-HCl buffer is 25 mM.

[0029] In one embodiment, the first electrical signal is converted to a first I-V curve and the second electrical signal is converted to a second I-V curve. D -V G curve. D -V G curve.

[0030] In one embodiment, the method further comprises the step of comparing the area of the first I-V curve and the second I-V curve to determine the amount of bacterial nucleic acid. D -V G curve. D -V G curve.

[0031] In one embodiment, the nucleic acid probe comprises a sequence of SEQ ID NO:1 that is specific to the Gram-negative bacteria, and the concentration of bacterial nucleic acid of the Gram-negative bacteria in the sample is at least 10 ag / μL.

[0032] In one embodiment, the nucleic acid probe comprises the sequence of SEQ ID NO: 2, and the concentration of the Gram-positive bacteria in the sample is at least 1 fg / μL.

[0033] Another object of this disclosure is to provide a sensor for detecting bacterial nucleic acids. The sensor includes an extended gate field-effect transistor (EGFET) having a sensing region; and a nucleic acid probe fixed to the sensing region, wherein the nucleic acid probe is specific for Gram-negative or Gram-positive bacteria.

[0034] In one embodiment, the nucleic acid probe comprises the sequence of SEQ ID NO:1, which is specific to the Gram-negative bacteria.

[0035] In one embodiment, the Gram-negative bacterium is *Escherichia coli* (E. coli). E. coli ).

[0036] In one embodiment, the nucleic acid probe comprises the sequence of SEQ ID NO:2, which is specific to the Gram-positive bacteria.

[0037] In one embodiment, the Gram-positive bacterium is Staphylococcus aureus (Staphylococcus aureus). S. aureus ).

[0038] In one embodiment, bacterial nucleic acid is detected by the following steps: providing a control group sample to the sensing region of the EGFET; detecting a first electrical signal of the EGFET after the control group sample is provided to the sensing region of the EGFET; providing a sample to the sensing region of the EGFET; and detecting a second electrical signal of the EGFET after the sample is provided to the sensing region of the EGFET.

[0039] In one embodiment, the first electrical signal is converted into a first I D -V G The curve, and the second electrical signal is converted into a second I D -V G curve.

[0040] In one embodiment, when the first I D -V G Curve and the second I D -V G When the curve is shifted, bacterial nucleic acid is present in the sample.

[0041] In one embodiment, the first I D -V G The area of the first I D -V G curve is compared to the area of the second I

[0042] It is another object of the present disclosure to provide a method for verifying the electrical properties of an EGFET. The method comprises the steps of: providing an EGFET in a first buffer solution having a first pH value; measuring a first electrical signal of the EGFET in the first buffer solution; providing a second buffer solution having a different pH value; providing the EGFET in the second buffer solution; measuring a second electrical signal of the EGFET in the second buffer solution; and converting the first electrical signal into a first I D -V G -V curve, and converting the second electrical signal into a second I D -V G -V curve.

[0043] In one embodiment, one of the first buffer solution, the second buffer solution, and the third buffer solution is a BTP buffer.

[0044] In one embodiment, the concentration of the BTP buffer is 10 mM.

[0045] In one embodiment, the different pH values include 5, 7, and 8.

[0046] In one embodiment, the EGFET is measured in the buffer solutions having different pH values in the order of pH 7, pH 5, pH 7, pH 8, and pH 7.

[0047] In one embodiment, the EGFET is a bare EGEFT.

[0048] It is another object of the present disclosure to provide a method for verifying the surface modification of an EGFET. The method comprises the steps of: measuring a first electrical signal of the EGFET in the buffer solution having the pH value; modifying the EGFET to form a modified EGFET; providing the modified EGFET in the buffer solution having the pH value; measuring a second electrical signal of the modified EGFET in the buffer solution having the pH value; converting the first electrical signal into a first I D -V G -V curve; and converting the second electrical signal into a second I D -V G -V curve.

[0049] In one embodiment, the buffer solution is a BTP buffer.

[0050] In one embodiment, the BTP buffer has a concentration of 10 mM.

[0051] In one embodiment, the EGFET is a bare EGEFT. BRIEF DESCRIPTION OF DRAWINGS

[0052] Figure 1A and Figure 1B An image of an extended gate field-effect transistor (EGFET) is shown; and Figure 1C A schematic diagram showing that an EGFET is composed of a MOSFET and an extended sensing membrane.

[0053] Figure 2 A schematic diagram showing a sensing system for DNA detection according to the present disclosure.

[0054] Figure 3 A schematic diagram showing a chemical reaction according to the present disclosure.

[0055] Figure 4 A schematic diagram showing the process before SEM analysis for verifying immobilized probes according to the present disclosure.

[0056] Figure 5 A to Figure 5 C shows the confirmation of different sizes of DNA by electrophoresis, wherein Figure 5 A shows synthetic DNA of 55 base pairs: Gram-negative target DNA (lane 1) and Gram-positive target DNA (lane 2); Figure 5 B shows gDNA extracted from E. coli (lane 1) and gDNA extracted from S. aureus (lane 2); and Figure 5 C shows that after thermal lysis, gDNA is broken into fragment DNA, the size of which is shorter than 4000 base pairs, gDNA extracted from E. coli (lane 1) and gDNA extracted from S. aureus (lane 2).

[0057] Figure 6A and Figure 6B A confirmation of primers by PCR is shown, which indicates that E. coli with a DNA size of 252 base pairs can be amplified using GN primers ( Figure 6A ), and S. aureus with a DNA size of 900 base pairs can be amplified using GP primers ( Figure 6B ).

[0058] Figure 7A to Figure 7DFigures showing the electrical properties of a bare EGFET confirmed by measuring electrical signals, wherein FIG. 7 and Figure 7B shows good electrical properties of an EGFET, i.e. stable baseline under normal conditions, and Figure 7C and Figure 7D shows bad electrical properties of an EGFET, i.e. unstable baseline under abnormal conditions (reaction conditions: 10 mM BTP buffer, Vd: 2V, VG: 0-3V).

[0059] Figure 8A and Figure 8B shows a graph of confirming the electrical properties of an EGFET according to the present disclosure.

[0060] Figure 9A to Figure 9D shows a graph of verifying surface modification according to the present disclosure by stepwise electrical measurement.

[0061] Figure 10A to Figure 10F shows a verification of surface modification by SEM according to the present disclosure.

[0062] Figure 11A and Figure 11B shows a graph of specificity of an EGFET according to the present disclosure for 55 base pairs of target DNA.

[0063] Figure 12A and Figure 12B shows a graph of specificity of an EGFET according to the present disclosure for gDNA.

[0064] Figure 13A to Figure 13F shows a graph of sensitivity of an EGFET according to the present disclosure for 55 base pairs of target DNA.

[0065] Figure 14A to Figure 14F shows a graph of sensitivity of an EGFET according to the present disclosure for gDNA of bacteria.

[0066] Figure 15A to Figure 15D shows a graph of buffer solution capable of causing minimal non-specific binding according to the present disclosure.

[0067] Figure 16A and Figure 16B shows a graph of specificity of an EGFET according to the present disclosure for bacterial gDNA spiked with 100-fold diluted fingertip blood.

[0068] Figure 17A to Figure 17F shows a graph of sensitivity of an EGFET according to the present disclosure for gDNA of bacteria spiked with 100-fold diluted fingertip blood.

[0069] Figure 18A to Figure 18FA graph showing the sensitivity of the EGFET according to this disclosure to bacterial samples incorporating 100-fold diluted fingertip blood is presented.

[0070] Figure 19A to Figure 19C The identification of the target DNA by SEM according to this disclosure is shown. Detailed Implementation

[0071] To assist in understanding the purpose, features, and effects of this disclosure, embodiments are provided and described in detail with reference to the accompanying drawings.

[0072] Material 3-Aminopropyltriethoxysilane (APTES) solution, glutaraldehyde (GA) solution, sodium cyanoborohydride (NaBH3CN), bis-tris propane (BTP), and streptavidin-conjugated gold nanoparticles (approximately 20 nm colloidal gold) were purchased from Sigma-Aldrich (USA). Tris powder was purchased from JTBaker (USA). Acetone and ethanol (98% & 99.5% & 99.8%) were purchased from Echo Chemicals. All solutions were diluted with DI water (resistivity 18.2 Ω) from an ultrapure water system (Millipore). Pure oxygen and nitrogen were purchased from Xin Fu Fa. The silicone elastomer Sylgard 184 A&B was purchased from SIL-MORE. The probe DNA, target DNA, and primer sequences were designed based on previous studies (Aarthi et al., Microbiological Research, 2013. 168(8): p. 497-503) and Primer-Blast (Ye et al., BMC Bioinformatics, 2012. 13(1): p. 134). All synthetic oligonucleotides were synthesized by Bio-Protech Technology Enterprise. DH5α Escherichia coli ( Escherichia coli E. coli), Staphylococcus aureus ( Staphylococcus aureus S. aureus and finger-prick blood were provided by the American Center for Type Culture Collection or Chang Gung Memorial Hospital and were cultured in the laboratory. The DNA MiniKit was purchased from Qiagen. A 100bp DNA Ladder H3 RTU (ready-to-use) was purchased from GeneDirex. Healthview nucleic acid staining reagent was purchased from P&C Biotech. One copy of Taq Quick-Load 2X Master Mix with standard buffer was purchased from Biolabs.

[0073] EGFETs were provided by SUNPLUS TECHNOLOGY (Hsinchu, Taiwan) and the chips were fabricated using standardized semiconductor processing technology. Figure 1A and Figure 1B Images of extended gate field-effect transistors (EGFETs) are shown, where in Figure 1A the left side, the boxes indicate the location of the sensing area are magnified under SEM at Figure 1A the right side to show the component structure. The length and width of the bare chip is 1 cm x 1 cm, and the sensing device is 100 pm x 100 pm, as shown in Figure 1A and Figure 1B As shown in Figure 1C , the EGFET is composed of a MOSFET and an extended sensing membrane, and the detection principle of EGFET and ISFET is similar, they are both through the electrochemical potential change between the electrolyte and the sensing membrane to adjust the gate potential. Therefore, it changes the channel conductivity between the source and the drain of the MOSFET and affects the drain current. D -V G The signal is affected by the charge collected by the floating gate and is transmitted to the test board by affecting the conductivity in the channel, causing the shift of the electrical curve (Guliga et al., Extended gate field effect transistor (EGFET) integrated readout interfacing circuit for pH sensing. in 2014 2nd International Conference on Electrical, Electronics and System Engineering (ICEESE). 2014; Dorfman et al., Biomicrofluidics, 2020. 14(1): p.011301).

[0074] Open well system The open-well system was made of polydimethylsiloxane (PDMS) and served as the loading channel for the sample. It was made by mixing Sylgard 184 A and Sylgard 184 B at a ratio of 10:1. A vacuum pump was used to remove air bubbles from the gel-like mixture. The mixture was poured into a mold that formed the open-well, then heated at 120°C for 10 minutes and left to cure at room temperature overnight. The PDMS was solid and was cut into shape for use. The PDMS was attached on top of the sensing area of the chip, and the PDMS channel could be loaded with 100 μΐ^ of sample and operated on the probe platform to measure the electrical signal.

[0075] Sensing system The sensing system is shown in Figure 2 . The sensing system contains a test board that measures the electrical characteristics of the chip, a computer with Python software Is0851 ver that analyzes the electrical signal, and an open-well system. The probe platform is set in a sealable metal chamber that provides electrostatic shielding to reduce external noise. The sensor has a constant drain voltage (V D ) of 2 V, and a gate voltage (V G ) scan of 0 V to 3 V is applied to the EGFET sensor, and the test board measures I D -V G response. The chip designed by Mediatek (Hsinchu, Taiwan) is an integrated circuit signal, not a pure FET device. The electrical signal is measured as I D -V G curve and converted to V out -V G curve by equation (1-1). The difference between the baseline area of each concentration is calculated. A significant difference is defined as the area difference of the target sample being at least three times the area difference of the negative control sample.

[0076] V out = I D x R (equation 1-1), where R is the resistance value.

[0077] Electrical measurement of EGFET Before the electrical signal measurement, 10 minutes were provided to stabilize the system. Then, three consecutive overlapping I D -V G curves were obtained. The I D -V GThe baseline of the curve is stable. Then, 10 mM of BTP buffer is removed from the open well. The negative control sample is added to the sample loading well and incubated for 30 minutes at room temperature. After 30 minutes, the negative control sample is removed and the well is washed with 10 mM of BTP buffer and pipetted three times to remove any non-specific binding. After 10 minutes of settling, the I D -V G Response. I D -V G The determination of the curve is measured from three consecutive overlapping I D -V G curves obtained to ensure that there is no change in signal. Next, the negative control sample is replaced with the biological sample and, following the negative control, the sample step is repeated, starting from low concentration to high concentration.

[0078] Surface modification of EGFETs The surface immobilization process utilizes self-assembled monolayers (SAMs) technology to attach and immobilize nucleic acid probes on the surface of EGFETs (Hasan et al., 6-Self-assembled monolayers in biomaterials, in Nanobiomaterials, R. Narayan, Editor. 2018, Woodhead Publishing. p. 137-178.; Murugan et al., Int J Biomed Eng Technol, 2009. 2(2): p. 104-134). Figure 3 A diagram showing the chemical reaction.

[0079] Chip cleaning is performed as follows. The chip is immersed in acetone for 10 minutes of ultrasonication, rinsed with 95% ethanol, and immersed in 95% ethanol for 10 minutes of ultrasonication. These organic solvents are used to remove contaminant particles from the chip surface, and then the chip is heated at 90°C for 1 minute to remove excess ethanol.

[0080] Oxygen plasma treatment is performed as follows. After the solution cleaning step is completed, the chip is placed in the plasma chamber of a plasma cleaner, PDC-32G (HARICK PLASMA). Excess air is pumped out, creating a vacuum in the sealed chamber, and pure oxygen is pumped in. After this, the oxygen level is 500-600 mTorr, and the high-intensity magnetic field is turned on for 1 minute. The oxygen plasma treatment not only cleans the chip but also makes the chip surface more hydrophilic by forming hydrophilic groups (-OH groups) on the chip surface. This step can improve the absorption of the subsequent coating or the bonding of functional groups.

[0081] APTES modification was performed as follows. The chip was immersed in APTES solution (2% in 99.8% anhydrous ethanol) and shaken at 60 rpm for 30 minutes at room temperature to form an amine group end monolayer on the chip surface. The chip was then cleaned with 99.5% ethanol three times and sonicated in 99.5% ethanol for 10 minutes to remove the remaining APTES residue. Finally, the chip was baked at 120 °C for 10 minutes to eliminate excess ethanol to induce the formation of amine groups to attach one end of APTES on the surface.

[0082] Glutaraldehyde modification was performed as follows. The chip with amine group end-capping was immersed in 2.5% GA solution in 10 mM BTP buffer and shaken at 60 rpm for 1 hour (in the dark) at room temperature to form terminal aldehyde groups. The chip was rinsed with 10 mM BTP buffer three times and blown dry with nitrogen.

[0083] DNA probe immobilization was performed as follows. The chip was incubated with 100 nM of amine-modified (5'-C6-NH2) DNA probes in 10 mM BTP buffer at 4 °C overnight. The DNA probe sequences are shown in Table 1, where Probe 1 is a 5'-amine-modified Gram-negative DNA probe (length: 37 bases), Probe 2 is a 5'-amine-modified Gram-positive DNA probe (length: 37 bases), Target 1 is a Gram-negative target DNA (length: 55 bases), and Target 2 is a Gram-positive target DNA (length: 55 bases). The amine in the DNA probes will attach to the terminal aldehyde groups left by GA.

[0084] Table 1

[0085] After 12 to 16 hours, the chip was rinsed with 10 mM BTP buffer and 10 mM Tris buffer three times. The chip was immersed in 4 mM NaBH3CN prepared in 10 mM Tris buffer for 30 minutes to stabilize the DNA probes and block the unreacted aldehyde groups. Then, the chip was rinsed with 10 mM BTP buffer three times and blown dry with nitrogen.

[0086] Verification of surface modification To confirm that the immobilization process used in the surface modification is sufficient to attach the probes to the surface of the EGFETs, two verification methods were designed. The first verification method uses the electrical signal of the chip to confirm the change in electrical characteristics during each step of the surface modification, and the second verification method uses scanning electron microscopy (SEM).

[0087] Verification by stepwise measurements: The chip surface modification was confirmed by measuring the I-V curves of the same chip after each surface immobilization step. D -V G The electrical properties after different stages of modification and sensing process, chip cleaning, APTES, GA, and probe immobilization were measured. After acetone and ethanol cleaning, the chip was dried with nitrogen, then 10 mM, pH 7 BTP buffer was poured to obtain three overlapping I-V curves. D -V G In the next step, the surface modification was performed with APTES, the mixture was heated at 120 °C for 10 minutes, then 10 mM, pH 7 BTP buffer was added in order to obtain three overlapping I-V curves. After this, the surface modification in GA solution was completed, then the chip was washed 3 times with 10 mM, pH 7 BTP buffer and blown dry with nitrogen. A drop of 10 mM, pH 7 BTP buffer was poured to obtain three overlapping I-V curves. D -V G In the last step, the probes were immobilized on the chip surface overnight. After overnight, the chip was rinsed with 10 mM, pH 7 BTP buffer and blown dry with nitrogen, then 10 mM, pH 7 BTP buffer was poured to obtain three overlapping I-V curves. D -V G In the last step, the probes were immobilized on the chip surface overnight. After overnight, the chip was rinsed with 10 mM, pH 7 BTP buffer and blown dry with nitrogen, then 10 mM, pH 7 BTP buffer was poured to obtain three overlapping I-V curves. D -V G In the last step, the probes were immobilized on the chip surface overnight. After overnight, the chip was rinsed with 10 mM, pH 7 BTP buffer and blown dry with nitrogen, then 10 mM, pH 7 BTP buffer was poured to obtain three overlapping I-V curves.

[0088] Verification by scanning electron microscopy (SEM): Each step of EGFET surface modification for SEM analysis was required, which was described in the following steps: (1) chip cleaning, (2) APTES modification, (3) glutaraldehyde modification, and (4) DNA capture probe immobilization, all steps were incubated in streptavidin-conjugated gold nanoparticles solution (1 / 10 dilution with gold nanoparticle dilution buffer) for 3 hours at room temperature. After incubation, the chip was washed with gold nanoparticle washing buffer and deionized water to remove non-specific binding. For SEM analysis, the chip was sputtered with platinum (Pt) before SEM scanning. SEM was performed by Integrated Service Technology (Hsinchu, Taiwan). Gold nanoparticles were observed under SEM images to verify the presence of DNA probes. The DNA probes listed in Table 1 were modified with biotin groups at the 3’ end, forming 3’-biotinylated Gram-negative DNA probes, 3’-biotinylated Gram-positive DNA probes, 3’-biotinylated Gram-negative target DNA, and 3’-biotinylated Gram-positive target DNA, respectively, which were able to capture streptavidin-conjugated gold nanoparticles (AuNPs) (Figure 1). Figure 4 ).

[0089] Sample preparation Bacteria preparation and quantification: Bacteria quantification was performed by completing cell culture before each biosensing. E. coli and S. aureus were suspended in 10 mM BTP buffer and their OD 600 units were tested using a UV-vis spectrophotometer (UV-3300, Hitachi). OD 600 units of 8 x 10 8 CFU / mL and 7 x 10 8 CFU / mL, respectively. After that, samples were diluted in 10 mM BTP buffer to different cell densities for testing and extraction.

[0090] Genomic DNA (gDNA) extraction: gDNA was extracted from E. coli and S. aureus, both of which are the main causes of sepsis. The cell density was quantified at 8 x 10 8 CFU / mL and the bacterial genomic DNA was extracted following the manufacturer's instructions of the DNeasy Mini Kit (Qiagen). The quality and purity of the genomic DNA were judged by reading the absorbance at 260 nm and the absorbance ratio at 260 nm and 280 nm, respectively, using a Nanodrop. The extracted gDNA was stored at -20 °C for further use.

[0091] PCR for confirming primers The reaction mixture for PCR of the bacterial 16S rRNA region was composed of 15 μL of the reaction, 5.9 μL of DI water, 7.5 μL of One Taq Quick-Load 2X Master Mix with standard buffer, 0.3 μL (10 μmol) of each primer (Table 2), and 1 μL of DNA, the thermal profile of which was initial denaturation at 94 °C for 5 minutes, followed by 30 cycles of denaturation at 94 °C for 30 seconds, annealing with the gram-negative primer (the gram-positive primer annealing temperature was 52 °C) at 61 °C for 30 seconds, extension at 68 °C for 1 minute, and finally extension at 68 °C for 5 minutes. The PCR product was separated by DNA gel electrophoresis, which was performed at 1.5% agar gel in 1X TAE buffer at 110 V for 25 minutes using a PowerPac Basic Power Supply (Bio-Rad).

[0092] Table 2

[0093] In Table 2, SEQ ID NO: 5 represents a gram-negative forward primer, SEQ ID NO: 6 represents a gram-negative reverse primer, SEQ ID NO: 7 represents a gram-positive forward primer, and SEQ ID NO: 8 represents a gram-positive reverse primer.

[0094] Sample processing and detection procedure for gDNA extraction in fingertip blood In the present disclosure, two methods for sample processing and detection are provided for detecting and differentiating E. coli and S. aureus in blood. One method is direct detection of bacterial nucleic acid in blood, and the other method is pre-processing of samples containing bacteria in blood for detection.

[0095] Spiked extraction gDNA in fingertip blood: As the blood of sepsis patients contains free DNA, it is possible to identify the bacteria that cause sepsis by detecting bacterial DNA in blood (Gutierrez et al., Open Forum Infectious Diseases, 2019. 6(4); Opota et al., Clinical Microbiology and Infection, 2015. 21(4): p. 323-331). The extracted bacterial genomic DNA was diluted to several concentrations and heated at 95°C for 10 minutes and cold-shocked for 3 minutes to unwind the DNA double strands. The gDNA was added to the fingertip blood diluted 100-fold with 25 mM Tris-HCl buffer. In I D -V G After the baseline of the curve was stable, a drop of 100-fold diluted fingertip blood was poured into the well and incubated at room temperature for 15 minutes. After 15 minutes, the 100-fold diluted fingertip blood was removed, and the well was washed with 10 mM BTP buffer and 10 mM BTP + 0.05% Tween-20 three times by suction to remove any non-specific binding before measuring I D -V G The curve before removing any non-specific binding. The first sample was a negative control group. A certain concentration of the negative control group was poured into the open well for 30 minutes; after 30 minutes, the negative control group sample was removed and the well was washed with BTP buffer. After the system was stabilized for 10 minutes, I D -V G The curve. Next, the negative control group sample was replaced with a biological sample, and the negative control group was followed, repeating the sample step from low concentration to high concentration.

[0096] Incorporated bacteria in fingertip blood: After quantification of bacteria using UV-vis spectrophotometer, all samples were diluted in 100-fold diluted whole blood to various cell densities with 25 mM Tris-HCl buffer. After that, these samples were heated to lysis at 95 °C for 10 min and cold shock for 3 min to destroy the membrane of cells. The samples were put into a centrifuge, centrifuged at 14,000 rpm for 10 min, and the supernatant (including bacterial gDNA) was aspirated for detection (Pilecky et al., Diagnostic Microbiology and Infectious Disease, 2019. 94(1): p. 7-14; Millar et al., Journal of Microbiological Methods, 2000. 42(2): p. 139-147; Dalla-Costa et al., Journal of Microbiological Methods, 2017. 140: p. 61-6). The electrical measurement step followed the step of extracting gDNA incorporated in fingertip blood.

[0097] Confirmation of DNA length The size of DNA length was determined by gel electrophoresis. In Figure 5 A, the bands show that both gram-positive and gram-negative bacteria synthesized DNA with 55 base pairs. The gDNA extracted from E. coli and S. aureus is shown in Figure 5 B. Before biosensing, the gDNA was heated at 95 °C for 10 min and cold shock for 3 min to unwind the DNA double strand, breaking the size of gDNA into Figure 5 DNA fragments shown in

[0098] Confirmation of primers by PCR with gel electrophoresis The designed primers effectively distinguished gram-positive and gram-negative bacteria, as shown in Figure 6A and Figure 6B . In Figure 6A , the GN primers were able to amplify the 16S rRNA sequence of gram-negative bacteria, with a band size of approximately 252 base pairs, while not being able to amplify the sequence of positive bacterial sequences. In Figure 6B , the GP primers were able to amplify the 16S rRNA sequence of gram-positive bacteria, with a band size of approximately 900 base pairs, while not being able to amplify the sequence of negative bacteria. These results show that both sets of primers can distinguish the gram nature of bacteria, and the properties of these two sets of primers can be used to design probe sequences immobilized on the chip.

[0099] Electrical characteristics of EGFET in aqueous solution EGFET bare die testing in a solution environment: To confirm whether the EGFET device has good electrical response after the manufacturing and packaging process, the I of the bare device was measured. D -V G Curves. The electrical properties of the bare device were analyzed in an aqueous solution environment (10 mM BTP, pH 7). D -V G The curve is obtained through the 2V constant drain voltage (V) of the EGFET sensor. d ) and 0V to 3V gate voltage (V G The measurement is done by scanning. The potential from the gate electrode can control the device's current. D -V G The curves were obtained by measuring in 10 mM BTP buffer and incubating for 10 minutes before each test. The baseline electrical signal curve is stable under normal conditions and it... Figure 7A and Figure 7B It is shown that instability under abnormal conditions occurs simultaneously. Figure 7C and Figure 7D As shown.

[0100] Under normal circumstances, a stable baseline can be measured in six or seven rounds, while under abnormal conditions, a baseline requires at least ten rounds to measure stability. Unstable shifts in the electrical profile may be caused by the wafer's manufacturing condition, or by improper handling during measurement, displacement of the die PDMS, and water leakage.

[0101] For this reason, we found that measuring the electrical properties of the bare chip before the fixed process allows for a faster and more stable baseline for the electrical measurements after the fixed process.

[0102] Bare and APTES-modified EGFET pH sensing: Electrical properties need to be measured in solutions with different pH values ​​to ensure the sensor can detect changes in environmental ions. The bare state of the EGFET was measured in 10 mM BTP buffer at different pH values. Figure 8A As shown in the figure, when the buffer solution is changed to a 10 mM, pH 5 BTP buffer, I D -V G The curve shifted to the left, and when the buffer was changed to a 10mM, pH 8 BTP buffer, I... D -V G The curve shifts to the right. The pH of the buffer solution used for detection changes in the order of pH 7, pH 5, pH 7, pH 8, pH 7.

[0103] APTES-modified EGFETs were measured in 10 mM BTP buffers with different pH values.Figure 8B As shown in the figure, when the buffer solution is changed to a 10 mM, pH 5 BTP buffer, I D -V G The curve shifted to the left, and when the buffer was changed to a 10mM, pH 8 BTP buffer, I... D -V G The curve shifts to the right. The pH of the buffer solution used for detection changes in the order of pH 7, pH 5, pH 7, pH 8, pH 7. Because APTES has an amino group at its terminal, its terminal is easily protonated in acidic solutions, generating a positive charge, thus increasing the drain current and causing I... D -V G The curve shifts to the left. These results show that the EGFET is sensitive to changes in surface potential.

[0104] Confirmation of surface modification Stepwise electrical measurements: Surface modification affects the potential of the EGFET. I is measured after all surface modification steps. D -V G The electrical response of the curve. First, a baseline is established after the chip cleaning step ( Figure 9A After APTES modification, I D -V G The curve shifts to the left because of the positive charge of the amino group at the end of APTES ( Figure 9A After GA modification, I D -V G The curve shifts to the right because uncharged glutaraldehyde binds to the positive charge of APTES. Figure 9B Finally, after DNA probe immobilization, the DNA phosphate backbone carries a negative charge, causing the ID-VG curve to shift to the right. Figure 9C Based on I D -V G The movement of the curve confirms that the DNA probe is immobilized on the surface of the EGFET.

[0105] Through I D -V G The electrical properties of the curves are used to measure and present the impact of each step of the reaction during a fixed process on the chip. Figure 9D As shown in the diagram, the amino group at the end of APTES has a positive charge, the aldehyde group at the end of GA is uncharged, and the DNA probe has a negative charge. These reactants are charged and lead to I... D -V G Curve displacement. The efficiency of the immobilization process and DNA probe immobilization is verified by measuring the electrical curve.

[0106] Verification of surface modification by SEM: Gold nanoparticles conjugated to DNA probes can be observed by SEM. DNA probes are modified with biotin on the 3' end and can be connected to their streptavidin-conjugated gold. After the surface modification step, at the end of each step of surface modification, the chip is incubated with its streptavidin-conjugated gold for 3 hours. According to Figure 10A to Figure 10C , the SEM images show that no gold nanoparticles are observed on the chip surface after chip cleaning, APTES modification, and GA modification. Figure 10D show that no gold nanoparticles are observed on the chip surface after the non-biotinylated DNA probes are immobilized on the chip. As shown in Figure 10E , after the biotinylated DNA probes are immobilized on the chip, many gold nanoparticles are observed on the chip surface. Figure 10F show the counting of gold nanoparticles by image J.

[0107] Gold nanoparticles are observed by SEM to verify surface modification and probe immobilization. Streptavidin-conjugated gold nanoparticles are bound to specific DNA capture probes, which are modified with a biotin group on the 3' end. As a result, no gold nanoparticles are observed on the bare, APTES-modified, and GA-modified states. After the DNA probes are immobilized, there are many gold nanoparticles on the chip surface.

[0108] Specificity for different lengths of DNA Synthetic DNA target with 55 base pairs: The target DNA with 55 base pairs was synthesized by Bio-Protech Technology Enterprise. The target DNA with 55 base pairs was detected by the sensor of the present disclosure, and the results are shown in FIG. 11. In Figure 11A gram-negative probe (GNP) is immobilized on the sensing area of the EGFET, the baseline is first measured in 10 mM BTP buffer, then the negative control sample 1 nM (gram-positive target DNA with 55 base pairs) is added to the well and incubated for 30 minutes, I D -V G curve (GP target 1 nM) approaches the baseline. Finally, the target sample 1 nM (gram-negative target DNA with 55 base pairs) is added to the well and incubated for 30 minutes, resulting in I D -V G curve shifts to the left (GN target 1 nM). In Figure 11BIn this process, a Gram-positive probe (GPP) is immobilized on the sensing region of an EGFET to establish a baseline. Then, a 1 nM negative control sample (a Gram-negative target DNA with 55 base pairs) is added to the well and incubated for 30 minutes to obtain a baseline-closed I0. D -V G Curve (GN target 1 nM). Finally, add 1 nM of the target sample (Gram-positive target DNA with 55 base pairs) to the well and incubate for 30 minutes, so that I D -V G The curve (GP target 1 nM) shifts to the left.

[0109] like Figure 11A and Figure 11B As shown in the diagram, the DNA probe hybridizes only with complementary DNA, making I D -V G Curve shift. The results show that the sensor of this disclosure exhibits good specificity for DNA targets with 55 base pairs.

[0110] Genomic DNA (gDNA) Target: gDNA was extracted from *E. coli* and *Staphylococcus aureus* using the DNA Mini Kit (Qiagen). The gDNA was heated at 95°C for 10 minutes, followed by cold shock for 3 minutes to denature and fragment the DNA. Figure 12A In this process, a Gram-negative probe (GNP) is immobilized on the sensing area of ​​an EGFET. First, a baseline is measured in 10 mM BTP buffer. Then, 1 ng / μL of a negative control group sample (Staphylococcus aureus gDNA) is added to the well. D -V G The curve was consistent with the baseline. Finally, 1 ng / μL of the target sample (E. coli gDNA) was added to the well, making I... D -V G The curve shifts to the left. Figure 12B In this process, Gram-positive probes (GPPs) were immobilized on the sensing area of ​​the EGFET to establish a baseline, and then 1 ng / μL of negative control group sample (E. coli gDNA) was added. D -V G The curve approached the baseline. Then, 1 ng / μL of the target sample (Staphylococcus aureus gDNA) caused I... D -V G The curve shifts to the left.

[0111] As shown in Figure 12, only targets that perfectly match the DNA probe can induce I. D -V GCurves displacement. Results show that using 16S rRNA sequence as DNA probe on EGFET is able to differentiate gDNA samples.

[0112] The sensor of the present disclosure is able to distinguish target DNA with 55 base pairs at 1 nM and is able to distinguish genomic DNA at 1 ng / L. As shown in Figures 11 and 12, the size of the DNA sequence does not affect the specificity of the sensor of the present disclosure.

[0113] Sensitivity to different length DNA Synthetic target DNA with 55 base pairs: Detection of target DNA with 55 base pairs at 100 fM, 10 pM, 1 nM, 100 nM on EGFET using Gram-negative probe, results are shown in Figure 13A Gram-negative probe (GNP) was immobilized on the sensing area of EGFET, baseline was measured in 10 mM BTP buffer, negative control group 1 nM of I D -V G Curves approach baseline. 100 fM of target DNA with 55 base pairs does not induce the same displacement as the control group. 10 pM of target DNA with 55 base pairs causes a slight displacement of I D -V G Curves. 1 nM and 100 nM of target DNA with 55 base pairs induce curves with greater displacement. Area difference is 0.75, 0.88, 2.67, 5.23 and 6.61, respectively, shown in Figure 13B Sensitivity slope graph extracted from hybridization test of Gram-negative target is shown in Figure 13E These results show that short DNA samples require a concentration of at least 10 pM to be detected.

[0114] Detection of target DNA with 55 base pairs at 100 fM, 10 pM, 1 nM and 100 nM on EGFET using Gram-positive probe, as shown in Figure 13C Gram-positive probe (GPP) was immobilized on the sensing area of EGFET, baseline was measured in 10 mM BTP buffer, negative control group 1 nM of I D -V G Curves approach baseline. 100 fM of target DNA with 55 base pairs does not induce displacement. 10 pM of target DNA with 55 base pairs causes a slight displacement of I D -V G Curves. 1 nM and 100 nM of target DNA with 55 base pairs induce curves with greater displacement. Area difference is 0.75, 0.88, 2.67, 5.23 and 6.61, respectively, shown in D -VG The area difference for 0.20, 0.24, 1.02, 2.15, and 4.55, respectively, is shown in Figure 13D The sensitivity slope plot extracted from the hybridization test of the gram-positive target is shown in Figure 13F

[0115] Genomic DNA (gDNA) target: The gram-negative probe was used to detect E. coli (gram-negative) gDNA at 0.1 ag / μL, 10 ag / μL, 1 fg / μL, and 10 pg / μL on the EGFET, which is shown in Figure 14A The gram-negative probe (GNP) was immobilized on the sensing area of the EGFET, and the baseline was measured in 10 mM BTP buffer, with a negative control of 1 ng of I D -V G The I-V curve approaches the baseline. As the gDNA concentration increases from 0.1 ag / μL to 10 pg / μL, the I-V curve gradually shifts to the left. The area difference between different concentrations of gDNA is 0.21, 0.37, 1.35, 1.47, 2.47, respectively, which is shown in D -V G The I-V curve gradually shifts to the left. The area difference between different concentrations of gDNA is 0.21, 0.37, 1.35, 1.47, 2.47, respectively, which is shown in Figure 14B The sensitivity slope plot extracted from the hybridization test of E. coli gDNA is shown in Figure 14E These results show that the E. coli gDNA sample requires at least a concentration of 10 ag / μL to be detected.

[0116] Gram-positive probe was used to detect S. aureus (gram-positive) gDNA at 0.1 ag / μL, 10 ag / μL, 1 fg / μL, and 10 pg / μL on the EGFET, which is shown in Figure 14C The gram-positive probe (GPP) was immobilized on the sensing area of the EGFET, and the baseline was measured in 10 mM BTP buffer, with a negative control of 1 ng of I D -V G The I-V curve approaches the baseline. As the gDNA concentration increases from 0.1 ag / μL to 10 pg / μL, the I-V curve gradually shifts to the left. The area difference between different concentrations of gDNA is 0.47, 0.92, 1.57, 2.01, and 2.68, respectively, which is shown in D -V G The I-V curve gradually shifts to the left. The area difference between different concentrations of gDNA is 0.47, 0.92, 1.57, 2.01, and 2.68, respectively, which is shown in Figure 14D The sensitivity slope plot extracted from the hybridization test of S. aureus gDNA is shown in Figure 14F These results show that the S. aureus gDNA sample requires at least a concentration of 10 ag / μL to be detected.

[0117] ​10 pM of target DNA with 55 base pairs was calculated with Equation (1-2) and converted to the correlation with the DNA concentration measured by Nanodrop. The results show that the concentration detection limit after conversion by the equation is 0.35 pg / µL. The detection limit of gDNA is 10 ag / µL by calculation using Equation (1-2).

[0118] M (Mole / L) = amount (ng / µL) / (base pair x 650) (Equation 1-2) Recently, studies have shown that the efficiency of a sensor platform for target detection depends on the ability of the receptor-target pair to induce a change in the surface charge density on the transducer layer, and there are two approaches to explain the change in the theory of surface potential regulation effects (Schöning et al., Label-Free Biosensing. Advanced Materials, Devices and Applications, Springer International Publishing, 2018). Considering the charged bilayer on top of the sensor surface, the direct influence of regulating the surface charge density on the binding of charged molecules can be described by the Poisson-Boltzmann theory. In the Poisson-Boltzmann theory, the negative charge of the nucleic acid within the Debye length is able to change the surface charge density of the biosensor surface, resulting in the detection of a signal. Another approach is the ion distribution theory, which describes the interfacial effects between the binding of charged biological molecules, which change the potential of the sensor, thereby regulating the ion concentration near the surface.

[0119] In FIGS. 13 and 14, the detection limit of the EGFET for target DNA with 55 base pairs is 10 pM (0.35 pg / µL). Bacterial gDNA can be detected by the EGFET at 10 ag / µL. These results indicate that the EGFET can detect DNA sequences of different lengths. In addition, long DNA sequences have better detection limits than short DNA sequences. Although longer nucleic acid sequences can be detected at lower concentrations, the displacement of the electrical signal is relatively small compared to shorter sequences. Because only a few long nucleic acids can bind to the chip surface, the length of the DNA can affect the rate and efficiency of DNA hybridization on the chip (Peplies et al., Applied and environmental microbiology, 2003. 69(3): p. 1397-1407; Peytavi et al., Biotechniques, 2005. 39(1): p. 89-96).

[0120] Dilution of fingertip blood with different buffers Fingertip blood was diluted with different buffer solutions before nucleic acid testing in whole blood (from human fingertip blood). The test was performed to determine which solution buffer has less non-specific interaction on the bare chip. Blood was diluted with 10 mM BTP buffer, 25 mM BTP buffer, 10 mM Tris-HCl buffer, and 25 mM Tris-HCl, respectively. The results are shown in FIG. 15. Blood diluted with 10 mM BTP buffer and 10 mM BTP + 0.05% Tween 20 wash after, blood diluted with 10 mM BTP buffer, 25 mM BTP buffer, and 10 mM Tris-HCl buffer, respectively, cannot be washed and they all have some non-specific binding on the surface of the EGFET. Figure 15A to Figure 15C ). In Figure 15D , non-specific binding caused by blood diluted with 25 mM Tris-HCl buffer can be washed, and I D -V G The curve shifts to the baseline.

[0121] Because there is no anticoagulant added to the dilution buffer of the present disclosure, some non-specific binding on the chip surface can occur after the blood is diluted for testing. The test results show that there is less non-specific interaction on the bare chip when the blood is diluted with 25 mM Tris-HCl buffer. Based on these results, the present disclosure provides a method for detecting bacteria or gDNA of a bacterial sample in diluted blood.

[0122] Specificity of 100-fold diluted fingertip blood spiked with bacterial gDNA gDNA was extracted from E. coli and S. aureus by DNA Mini Kit (Qiagen). The gDNA was heated at 95 °C for 10 minutes and cold shocked for 3 minutes to denature and fragment the DNA. The gDNA was spiked into 100-fold diluted fingertip blood with 25 mM Tris-HCl buffer. In Figure 16A , the gram-negative probe (GNP) was immobilized on the sensing area of the EGFET, the baseline was measured in 10 mM BTP buffer, then a drop of 100-fold diluted fingertip blood was poured into the well to establish a new baseline. The negative control sample 1 ng / μL (gDNA of S. aureus) was added to the well, I D -V G The curve coincides with the new baseline. Subsequently, the target sample 1 ng / μL (gDNA of E. coli) was added to the well, resulting in I D -V G The curve shifts to the right.Figure 16B In FIG. 16, the results show that using 16S rRNA sequence as DNA probe on EGFET is able to differentiate gDNA samples in blood, and diluting blood with 25 mM Tis-HCl buffer causes little or no non-specific binding on the chip surface. D -V G The curve approaches the new baseline. Subsequently, the target sample 1 ng / μL (gDNA of S. aureus) causes I D -V G The curve shifts to the right.

[0123] In FIG. 16, the results show that using 16S rRNA sequence as DNA probe on EGFET is able to differentiate gDNA samples in blood, and diluting blood with 25 mM Tis-HCl buffer causes little or no non-specific binding on the chip surface.

[0124] Sensitivity of 100-fold diluted finger prick blood spiked with bacterial gDNA Gram-negative probe was used to detect 10 ag / μL, 1 fg / μL, and 100 fg / μL of E. coli (gram-negative) gDNA in 100-fold diluted finger prick blood on EGFET. The results are shown in Figure 17A In FIG. 16, the results show that using 16S rRNA sequence as DNA probe on EGFET is able to differentiate gDNA samples in blood, and diluting blood with 25 mM Tis-HCl buffer causes little or no non-specific binding on the chip surface. D -V G The curve approaches the baseline. When the target gDNA concentration increases from 10 ag / μL to 100 fg / μL, I D -V G The curve gradually shifts to the right. The area difference between different concentrations of gDNA is 0.73, 2.62, 4.06, and 5.13, respectively, as shown in Figure 17B In FIG. 16, the results show that using 16S rRNA sequence as DNA probe on EGFET is able to differentiate gDNA samples in blood, and diluting blood with 25 mM Tis-HCl buffer causes little or no non-specific binding on the chip surface. Figure 17E The sensitivity slope plot of E. coli gDNA hybridization test extracted from blood is shown in FIG. 16. These results show that E. coli gDNA sample requires at least 10 ag / μL concentration to be detected.

[0125] Gram-positive probe was used to detect 10 ag / μL, 1 fg / μL, and 100 fg / μL of S. aureus (gram-positive) gDNA in 100-fold diluted finger prick blood on EGFET. The results are shown in Figure 17C In FIG. 16, the results show that using 16S rRNA sequence as DNA probe on EGFET is able to differentiate gDNA samples in blood, and diluting blood with 25 mM Tis-HCl buffer causes little or no non-specific binding on the chip surface. D -VG The curve is close to the baseline. When the target gDNA concentration is increased from 10 ag / μL to 100 fg / μL, I... D -V G The curve gradually shifts to the right. The area differences between different concentrations of gDNA are 0.71, 0.68, 2.11, and 2.81, respectively. Figure 17D The sensitivity slope plot of the Staphylococcus aureus gDNA hybridization assay extracted from blood is shown in [the figure]. Figure 17F As shown in the figure. These results indicate that a concentration of at least 1 fg / μL is required for the detection of Staphylococcus aureus gDNA samples.

[0126] Detection was performed using finger-prick blood diluted 100-fold with gDNA incorporated to simulate testing of samples from patients with sepsis. This confirmed that bacterial gDNA in the blood could be detected by the sensor of this disclosure. As shown in Figure 17, the detection limits for the 100-fold diluted finger-prick blood with gDNA incorporated were 1 fg / μL and 10 ag / μL, respectively, using Gram-positive and Gram-negative probes.

[0127] Sensitivity to 100-fold diluted fingertip blood containing bacteria After bacterial quantification, all samples were diluted 100-fold with 25 mM Tris-HCl buffer to various cell densities in whole blood. Subsequently, these samples were lysed at 95°C for 10 minutes, centrifuged, and the supernatant was collected for analysis. Figure 18A In this process, Gram-negative probes (GNPs) are immobilized on the sensing area of ​​the EGFET. Once the baseline is stable, 100-fold diluted finger-prick blood is added to the well to establish a new baseline. The negative control group contains Staphylococcus aureus. 8 CFU / mL of I D -V G The curve approaches baseline. When the concentration of *E. coli* gDNA increases from 10 CFU / mL to 10... 4 At CFU / mL, I D -V G The curve gradually shifts to the right. The area differences between different cell densities were 0.21, 0.53, 0.99, 1.50, and 2.42, respectively. Figure 18B The sensitivity slope plot of hybridization assay extraction from pretreated E. coli samples in blood is shown in [the figure]. Figure 18E The results show that E. coli samples require at least 10 [units of measurement missing]. 2 The concentration of CFU / mL is used for detection.

[0128] exist Figure 18CIn this case, the gram-positive probe (GPP) was immobilized on the sensing area of the EGFET. After the baseline was stabilized, 100-fold diluted fingertip blood was added to the well to establish a new baseline. The negative control group was E. coli 10 8 CFU / mL of S. aureus D -V G The curve approached the baseline. When the S. aureus gDNA concentration increased from 10 2 CFU / mL to 10 8 CFU / mL, the I D -V G curve gradually shifted to the right. The area difference between different cell densities was 0.22, 0.32, 1.64, 3.08, and 5.97, respectively, which is shown in Figure 18D . The sensitivity slope graph of the hybridization test extraction from the S. aureus sample pretreatment from blood is shown in Figure 18F . These results show that the S. aureus sample requires a concentration of at least 10 4 CFU / mL to be detected.

[0129] The present disclosure provides another method of detecting bacterial gDNA by using thermal lysis to pretreat the test sample from a sepsis patient. As shown in FIG. 18, by using the gram-positive probe and the gram-negative probe, the detection limit of the bacterial sample spiked in 100-fold diluted fingertip blood was 10 4 CFU / mL and 10 2 CFU / mL, respectively. The sensor of the present disclosure is able to distinguish whether the gDNA in the patient blood sample is low in concentration or absent. Accordingly, the present disclosure provides a method and a sensor for detecting sepsis. When a sepsis patient is infected, the blood contains the bacteria that causes the disease. The bacterial DNA in the blood can be extracted for detection. The method and sensor of the present disclosure provide an efficient and fast way to identify the gram nature of the bacterial species in the blood of a sepsis patient.

[0130] Target DNA confirmed by SEM The target DNA was modified with a biotin group at the 3' end and was able to connect with its streptavidin-conjugated nanogold. Figure 19A It is shown that after incubating the non-biotinylated target DNA for 30 minutes, no nanogold particles were observed on the surface of the chip. Figure 19B It is shown that after incubating the biotinylated target DNA for 30 minutes, many nanogold particles were observed on the surface of the chip. Figure 19C The nanogold particle count of image J is shown.

[0131] In the present disclosure, the EGFET of the sensor is able to detect DNA of different sizes with sufficient sensitivity. The sensitivity of GNP and GPP to 55 base pairs and gDNA is 10 pM (0.35 pg / μL) and 10 ag / μL, respectively. In the present disclosure, probes are designed to distinguish between Gram bacteria and two methods are provided to detect test samples from sepsis patients. In the method of the present disclosure, 100-fold diluted gDNA spiked in blood can be detected, with a sensitivity of 10 ag / μL for E. coli and 1 fg / μL for S. aureus using GNP and GPP, and 100-fold diluted bacterial samples spiked in blood can be detected, with a sensitivity of 10 2 CFU / mL for E. coli and 10 4 CFU / mL for S. aureus using GNP and GPP.

[0132] The present disclosure shortens the detection time of sepsis. Rapid identification of pathogens in blood will help appropriate treatment, reduce mortality, limit the use of broad-spectrum antibiotics and reduce the emergence of drug-resistant bacteria. Molecular detection methods have advantages because they do not rely on bacterial growth and have higher sensitivity for detecting low concentrations of pathogenic bacteria.

[0133] Although the present disclosure has been described in terms of specific embodiments, it will be apparent to those skilled in the art that numerous modifications and variations are possible without departing from the scope and spirit of the present disclosure as set forth in the claims. CLAIM (AMENDED IN ACCORDANCE WITH ARTICLE 19 OF THE TREATY) 1. A method of detecting bacterial nucleic acid, comprising the steps of: providing an extended gate field effect transistor (EGFET) having a sensing region; fixing a nucleic acid probe on the sensing region, wherein the nucleic acid probe has specificity for Gram-negative or Gram-positive bacteria; providing a control group sample on the sensing region of the EGFET; detecting a first electrical signal of the EGFET after the control group sample is provided on the sensing region of the EGFET; providing a sample on the sensing region of the EGFET; detecting a second electrical signal of the EGFET after the sample is provided on the sensing region of the EGFET; and comparing the first electrical signal and the second electrical signal to determine whether bacterial nucleic acid is present in the sample. 2. The method of claim 1, wherein the nucleic acid probe comprises a sequence of SEQ ID NO: 1 specific to the Gram-negative bacteria. 3. The method of claim 1, wherein the Gram-negative bacteria is Escherichia coli. 4. The method of claim 1, wherein the nucleic acid probe comprises a sequence of SEQ ID NO: 2 specific to the Gram-positive bacteria. 5. The method of claim 1, wherein the Gram-positive bacteria is Staphylococcus aureus. 6. The method of claim 1, wherein the sample is diluted with Tris-HCl buffer. 7. The method of claim 6, wherein the concentration of Tris-HCl buffer is 25 mM. 8. The method of claim 1, wherein the first electrical signal is converted to a first I-V curve, and the second electrical signal is converted to a second I-V curve. D -V G curve. D -V G curve. 9. The method of claim 8, wherein the presence of bacterial nucleic acid in the sample is indicated when there is a shift in the first I-V curve and the second I-V curve. D -V G curve. D -V G curve. 10. The method of claim 9, wherein the nucleic acid probe comprises a sequence of SEQ ID NO: 1 specific to the Gram-negative bacteria, and the concentration of bacterial nucleic acid of the Gram-negative bacteria in the sample is at least 10 ag / μL. 11. The method of claim 9, wherein the nucleic acid probe comprises a sequence of SEQ ID NO: 2, and the concentration of the Gram-positive bacteria in the sample is at least 1 fg / μL. 12. A method of detecting bacterial nucleic acid, comprising the steps of: providing an extended gate field effect transistor (EGFET) having a sensing region; fixing a nucleic acid probe on the sensing region, wherein the nucleic acid probe is specific to Gram-negative bacteria or Gram-positive bacteria; providing a control group sample on the sensing region of the EGFET; detecting a first electrical signal of the EGFET after the control group sample is provided on the sensing region of the EGFET; providing a sample on a sensing region of the EGFET, wherein the sample is diluted with a Tris-HCl buffer; detecting a second electrical signal of the EGFET after the sample is provided on the sensing region of the EGFET; and determining an amount of bacterial nucleic acid in the sample based on the first electrical signal and the second electrical signal. 13. The method of claim 12, wherein the nucleic acid probe comprises a sequence of SEQ ID NO: 1 specific to the Gram-negative bacteria. 14. The method of claim 12, wherein the Gram-negative bacteria is Escherichia coli. 15. The method of claim 12, wherein the nucleic acid probe comprises a sequence of SEQ ID NO: 2 specific to the Gram-positive bacteria. 16. The method of claim 12, wherein the Gram-positive bacteria is Staphylococcus aureus. 17. The method of claim 12, wherein the Tris-HCl buffer has a concentration of 25 mM. 18. The method of claim 12, wherein the first electrical signal is converted to a first I-V curve, and the second electrical signal is converted to a second I-V curve. D -V G curve. D -V G curve. 19. The method of claim 18, further comprising the step of comparing an area of the first I-V curve and the second I-V curve to determine an amount of bacterial nucleic acid. D -V G curve. D -V G curve. 20. The method of claim 19, wherein the nucleic acid probe comprises a sequence of SEQ ID NO: 1 specific to the Gram-negative bacteria, and the concentration of bacterial nucleic acid of the Gram-negative bacteria in the sample is at least 10 ag / pL. 21. The method of claim 19, wherein the nucleic acid probe comprises a sequence of SEQ ID NO: 2, and the concentration of the Gram-positive bacteria in the sample is at least 1 fg / pL. 22. A sensor for detecting bacterial nucleic acid, comprising: an extended gate field effect transistor (EGFET) having a sensing region; and a nucleic acid probe immobilized on the sensing region, wherein the nucleic acid probe is specific to a gram-negative or gram-positive bacteria, the nucleic acid probe comprising a sequence of SEQ ID NO: 1 specific to the gram-negative bacteria. 23. The sensor of claim 22, wherein the gram-negative bacteria is Escherichia coli. 24. A sensor for detecting bacterial nucleic acid, comprising: an extended gate field effect transistor (EGFET) having a sensing region; and a nucleic acid probe immobilized on the sensing region, wherein the nucleic acid probe comprises a sequence of SEQ ID NO: 2 specific to the gram-positive bacteria. 25. The sensor of claim 24, wherein the gram-positive bacteria is Staphylococcus aureus. 26. A method for verifying an electrical property of an EGFET, comprising the steps of: providing an EGFET in a first buffer solution having a first pH value; measuring a first electrical signal of the EGFET in the first buffer solution; providing a second buffer solution having a different pH value; providing the EGFET in the second buffer solution; measuring a second electrical signal of the EGFET in the second buffer solution; and converting the first electrical signal to a first I-V curve and the second electrical signal to a second I-V curve. D -V G D -V G one of the first buffer solution, the second buffer solution, and the third buffer solution is a BTP buffer. 27. The method of claim 26, wherein the BTP buffer has a concentration of 10 mM. 28. The method of claim 26, wherein the different pH values comprise 5, 7, and 8. 29. The method of claim 28, wherein the EGFET is measured in the buffer solutions having different pH values in the order of pH 7, pH 5, pH 7, pH 8, and pH 7. 30. The method of claim 26, wherein the EGFET is a bare EGEFT. 31. A method for verifying a surface modification of an EGFET, comprising the steps of: providing an EGFET in a buffer solution having a pH value; ​​measuring a first electrical signal of the EGFET in the buffered solution having the pH value; modifying the EGFET to form a modified EGFET; providing the modified EGFET in the buffered solution having the pH value; measuring a second electrical signal of the modified EGFET in the buffered solution having the pH value; converting the first electrical signal to a first I-V curve; D -V G curve; and converting the second electrical signal to a second I-V curve. D -V G curve. 32. The method of claim 31, wherein the buffered solution is a BTP buffer. 33. The method of claim 32, wherein the BTP buffer has a concentration of 10 mM. 34. The method of claim 31, wherein the EGFET is a bare EGEFT.

Claims

1. A method for detecting bacterial nucleic acid, comprising the following steps: Provides an extended gate field-effect transistor (EGFET) with a sensing region; A nucleic acid probe is fixed on the sensing area, wherein the nucleic acid probe is specific for Gram-negative or Gram-positive bacteria; A control group sample is provided on the sensing area of ​​the EGFET; After the control group sample is provided onto the sensing area of ​​the EGFET, the first electrical signal of the EGFET is detected; A sample is provided on the sensing area of ​​the EGFET; After the sample is provided onto the sensing area of ​​the EGFET, a second electrical signal of the EGFET is detected; as well as The first electrical signal is compared with the second electrical signal to determine whether bacterial nucleic acid is present in the sample.

2. The method of claim 1, wherein the nucleic acid probe comprises the sequence of SEQ ID NO: 1, which is specific to the Gram-negative bacteria.

3. The method according to claim 1, wherein the Gram-negative bacterium is Escherichia coli.

4. The method of claim 1, wherein the nucleic acid probe comprises the sequence of SEQ ID NO:2, which is specific to the Gram-positive bacteria.

5. The method according to claim 1, wherein the Gram-positive bacterium is Staphylococcus aureus.

6. The method of claim 1, wherein the sample is diluted with Tris-HCl buffer.

7. The method of claim 6, wherein the concentration of the Tris-HCl buffer is 25 mM.

8. The method according to claim 1, wherein the first electrical signal is converted into a first I D -V G The curve, and the second electrical signal is converted into a second I D -V G curve.

9. The method of claim 8, wherein when the first I D -V G Curve and the second I D -V G When the curve is shifted, bacterial nucleic acid is present in the sample.

10. The method of claim 9, wherein the nucleic acid probe comprises the sequence of SEQ ID NO: 1, which is specific to the Gram-negative bacteria, and the concentration of bacterial nucleic acid of the Gram-negative bacteria in the sample is at least 10 ag / μL.

11. The method of claim 9, wherein the nucleic acid probe comprises the sequence of SEQ ID NO: 2, and the concentration of the Gram-positive bacteria in the sample is at least 1 fg / μL.

12. A method for detecting bacterial nucleic acid, comprising the following steps: Provides an extended gate field-effect transistor (EGFET) with a sensing region; A nucleic acid probe is fixed on the sensing area, wherein the nucleic acid probe is specific for Gram-negative or Gram-positive bacteria; A control group sample is provided on the sensing area of ​​the EGFET; After the control group sample is provided onto the sensing area of ​​the EGFET, the first electrical signal of the EGFET is detected; A sample is provided on the sensing area of ​​the EGFET; After the sample is provided onto the sensing area of ​​the EGFET, a second electrical signal of the EGFET is detected; as well as Based on the first electrical signal and the second electrical signal, the amount of bacterial nucleic acid in the sample is determined.

13. The method of claim 12, wherein the nucleic acid probe comprises the sequence of SEQ ID NO: 1, which is specific to the Gram-negative bacteria.

14. The method of claim 12, wherein the Gram-negative bacterium is Escherichia coli.

15. The method of claim 12, wherein the nucleic acid probe comprises the sequence of SEQ ID NO:2, which is specific to the Gram-positive bacteria.

16. The method of claim 12, wherein the Gram-positive bacterium is Staphylococcus aureus.

17. The method of claim 12, wherein the sample is diluted with Tris-HCl buffer.

18. The method of claim 17, wherein the concentration of the Tris-HCl buffer is 25 mM.

19. The method of claim 12, wherein the first electrical signal is converted into a first I D -V G The curve, and the second electrical signal is converted into a second I D -V G curve.

20. The method of claim 19, further comprising comparing the first I D -V G Curve and the second I D -V G The area under the curve is used to determine the amount of bacterial nucleic acid.

21. The method of claim 20, wherein the nucleic acid probe comprises a sequence of SEQ ID NO: 1 specific to the Gram-negative bacteria, and the concentration of bacterial nucleic acid of the Gram-negative bacteria in the sample is at least 10 ag / μL.

22. The method of claim 20, wherein the nucleic acid probe comprises the sequence of SEQ ID NO: 2, and the concentration of the Gram-positive bacteria in the sample is at least 1 fg / μL.

23. A sensor for detecting bacterial nucleic acid, comprising: Extended gate field-effect transistor (EGFET) with a sensing region; and A nucleic acid probe is fixed on the sensing area, wherein the nucleic acid probe is specific for Gram-negative or Gram-positive bacteria.

24. The sensor of claim 23, wherein the nucleic acid probe comprises the sequence of SEQ ID NO: 1, which is specific to the Gram-negative bacteria.

25. The sensor of claim 23, wherein the Gram-negative bacterium is Escherichia coli.

26. The sensor of claim 23, wherein the nucleic acid probe comprises the sequence of SEQ ID NO:2, which is specific to the Gram-positive bacteria.

27. The sensor of claim 23, wherein the Gram-positive bacterium is Staphylococcus aureus.

28. The sensor of claim 23, wherein bacterial nucleic acid is detected by the following steps: providing a control group sample on the sensing region of the EGFET; and detecting a first electrical signal of the EGFET after the control group sample is provided on the sensing region of the EGFET. A sample is provided on the sensing area of ​​the EGFET; And after the sample is provided onto the sensing area of ​​the EGFET, a second electrical signal of the EGFET is detected.

29. The sensor of claim 28, wherein the first electrical signal is converted into a first I D -V G The curve, and the second electrical signal is converted into a second I D -V G curve.

30. The sensor of claim 28, wherein when the first I D -V G Curve and the second I D -V G When the curve is shifted, bacterial nucleic acid is present in the sample.

31. The sensor according to claim 28, wherein the first I D -V G Curve and the second I D -V G The area under the curves is compared to determine the amount of bacterial nucleic acid.

32. A method for verifying the electrical properties of an EGFET, comprising the following steps: EGFET is provided in a first buffer solution having a first pH value; Measure the first electrical signal of the EGFET in the first buffer solution; Provide a second buffer solution with a different pH value; The EGFET is provided in the second buffer solution; Measure the second electrical signal of the EGFET in the second buffer solution; as well as Convert the first electrical signal into a first I D -V G The curve, and convert the second electrical signal into a second I D -V G curve.

33. The method of claim 32, wherein one of the first buffer solution, the second buffer solution, and the third buffer solution is a BTP buffer.

34. The method of claim 33, wherein the concentration of the BTP buffer is 10 mM.

35. The method of claim 32, wherein the different pH values ​​include 5, 7, and 8.

36. The method of claim 35, wherein the EGFET is measured in the buffer solution having different pH values ​​in the order of pH 7, pH 5, pH 7, pH 8 and pH 7.

37. The method of claim 32, wherein the EGFET is a bare EGFET.

38. A method for verifying surface modifications of EGFETs, comprising the following steps: EGFETs are provided in a buffer solution with a pH value; The first electrical signal of the EGFET is measured in the buffer solution having the pH value; The EGFET is modified to form a modified EGFET; The modified EGFET is provided in the buffer solution having the pH value; The second electrical signal of the modified EGFET was measured in the buffer solution having the pH value; Convert the first electrical signal into a first I D -V G Curve; and The second electrical signal is converted into a second I D -V G curve.

39. The method of claim 38, wherein the buffer solution is a BTP buffer.

40. The method of claim 39, wherein the concentration of the BTP buffer is 10 mM.

41. The method of claim 38, wherein the EGFET is a bare EGFET.